The glamour and gloom of glycogen synthase kinase-3
- PMID: 15102436
- DOI: 10.1016/j.tibs.2003.12.004
The glamour and gloom of glycogen synthase kinase-3
Abstract
Glycogen synthase kinase-3 (GSK3) is now recognized as a key component of a surprisingly large number of cellular processes and diseases. Several mechanisms play a part in controlling the actions of GSK3, including phosphorylation, protein complex formation, and subcellular distribution. These are used to control and direct the far-reaching influences of GSK3 on cellular structure, growth, motility and apoptosis. Dysregulation of GSK3 is linked to several prevalent pathological conditions, such as diabetes and/or insulin resistance, and Alzheimer's disease. Therefore, much effort is currently directed towards understanding the functions and control of GSK3, and identifying methods capable of diminishing the deleterious impact of GSK3 in pathological conditions.
Similar articles
-
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.Neurochem Res. 2007 Apr-May;32(4-5):577-95. doi: 10.1007/s11064-006-9128-5. Epub 2006 Aug 30. Neurochem Res. 2007. PMID: 16944320 Free PMC article. Review.
-
Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.Curr Pharm Des. 2004;10(10):1105-37. doi: 10.2174/1381612043452668. Curr Pharm Des. 2004. PMID: 15078145 Review.
-
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061. Rev Neurosci. 2011. PMID: 22718609 Review.
-
Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions.PLoS One. 2012;7(7):e40250. doi: 10.1371/journal.pone.0040250. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792253 Free PMC article.
-
Glycogen synthase kinase 3: more than a namesake.Br J Pharmacol. 2009 Mar;156(6):885-98. doi: 10.1111/j.1476-5381.2008.00085.x. Epub 2009 Mar 4. Br J Pharmacol. 2009. PMID: 19366350 Free PMC article. Review.
Cited by
-
Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury.Int J Clin Exp Pathol. 2013 Jun 15;6(7):1282-93. Print 2013. Int J Clin Exp Pathol. 2013. PMID: 23826409 Free PMC article.
-
Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?BMC Neurosci. 2012 Oct 18;13:125. doi: 10.1186/1471-2202-13-125. BMC Neurosci. 2012. PMID: 23075086 Free PMC article.
-
Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.Eur J Pharmacol. 2013 Jan 5;698(1-3):252-8. doi: 10.1016/j.ejphar.2012.10.018. Epub 2012 Oct 23. Eur J Pharmacol. 2013. PMID: 23099259 Free PMC article.
-
Sevoflurane alleviates oxygen-glucose deprivation/reoxygenation-induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway.Exp Ther Med. 2021 Apr;21(4):376. doi: 10.3892/etm.2021.9807. Epub 2021 Feb 19. Exp Ther Med. 2021. PMID: 33732349 Free PMC article.
-
The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.Oncotarget. 2016 May 10;7(19):27538-51. doi: 10.18632/oncotarget.8485. Oncotarget. 2016. PMID: 27050373 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical